Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSX: $ACB.TO) (NYSE: $ACB) (TSX.V: $PURE.V) (OTC: $PRCNF) (CSE: $MTEC.C) (OTCPK: $CANVF) (CSE: $DIXI.U.C) (TSX: $WEED.TO) (NYSE: $CGC) (CSE: $SAFE.C)
Delta, Kelowna, BC - January 14, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSX: $ACB.TO) (NYSE: $ACB) (TSX.V: $PURE.V) (OTC: $PRCNF) (CSE: $MTEC.C) (OTCPK: $CANVF) (CSE: $DIXI.U.C) (TSX: $WEED.TO (NYSE: $CGC) (CSE: $SAFE.C)
Hear Investor ideas cannabis potcast on iTunes
Today's podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com "potcast", looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we will be looking at announcements from Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB), Pure Global Cannabis Inc. (TSX.V:PURE) (OTC: PRCNF), Cannvas MedTech Inc. (CSE: MTEC) (OTCPK: CANVF), Dixie Brands Inc. (CSE: DIXI.U), Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and 3 Sixty Risk Solutions Ltd. (CSE: SAFE).
Aurora Cannabis Inc. announced today that the Company has entered into a letter of intent to acquire all the issued and outstanding shares of privately held Whistler Medical Marijuana Corporation, in an all-share transaction valued at up to approximately $175 million, including certain milestone payments.
Located in Whistler, British Columbia, Whistler has developed one of Canada's most iconic cannabis brands, built on quality, award-winning organic certified BC bud. The Transaction is expected to provide Aurora with a premium and differentiated organic certified product suite, expanding both its medical and adult-use offerings, and reinforcing Aurora's presence in the well-established west coast cannabis market.
Whistler has developed a strong reputation with patients and adult-use consumers alike for providing premium quality cannabis products. Founded in 2013, Whistler is one of Canada's original ten licensed producers, and was the first licensed producer to obtain organic certification and sell a full suite of organic certified cannabis products.
Whistler operates two indoor licensed production facilities, with its first located in Whistler, British Columbia, and the second, a recently licensed, purpose-built, state-of-the-art facility located a 20-minute drive from the Whistler facility. Once the second facility reaches full capacity (anticipated for Summer 2019) the facilities are anticipated to have a combined production capacity of over 5,000 kg per year. Whistler sells medical cannabis derivatives internationally to both Australia and the Cayman Islands, and through the addition of Aurora's deep experience in completing EU GMP certified facilities and its large global distribution network, Aurora plans to pursue additional international export opportunities.
Pure Global Cannabis Inc. an integrated, growth-oriented life sciences and consumer products cannabis company, through its subsidiary PureSinse Inc., announced that Health Canada has issued PureSinse a Sales License under the Cannabis Act.
Eligible and pre-registered Canadian medical patients can soon select from two dozen premium cannabis products offered by PureSinse, via its newly launched eCommerce website at PureSinse.com. The Company is committed to supporting medical cannabis patients by emphasizing the quality of and access to the products they need. The Company anticipates growing to 70 SKUs (stock-keeping units) by mid-2019, including adding extracted oil products, and vape pens.
Cannvas MedTech Inc., a leading digital cannabis educator and business technology company, announced its plans to form an independent panel of esteemed and established scientific consultants from across a range of industries to provide oversight and original content to the Cannvas.Me digital cannabis education platform. Members of the newly-formed Cannabis Sciences Advisory Board are expected to be announced in early 2019.
"We are excited to bring together scientific experts from within and outside the cannabis industry to contribute their wealth of knowledge and experience in ensuring the educational content on Cannvas.Me remains relevant as it pertains to the latest in cannabis and health sciences," said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. "As researchers continue to unravel the science of cannabis and solve new and potentially industry-disrupting mysteries surrounding the plant and its uses - such as the developing argument of classifying cannabis by terpene profiles instead of strain names - our Cannabis Sciences Advisory Board will help ensure Cannvas.Me users continue to receive up-to-date research-based information in an easy-to-learn format."
The newly-formed Cannabis Sciences Advisory Board joins the independent Medical Advisory Board and Educational Advisory Panel already established at Cannvas.Me. The two existing boards are made up of licenced health practitioners and certified educators from Canada and the United States. The Cannabis Sciences Advisory Board will also include prominent Canadians and Americans who are among the leaders in their fields with robust backgrounds in education, health sciences, medicine and research. Members of the Board will be in constant communication with the Cannvas.Me team to offer guidance on new educational modules, oversight of and contributions to original Cannvas.Me content, and insights into health sciences, clinical trials, medical and scientific regulatory affairs, and other related topics.
Dixie Brands Inc., one of the cannabis industry's leading consumer packaged goods companies, has announced new leadership and priorities for its pet wellness company Therabis. Dixie has hired specialty pet food and CPG veteran Bob Rubin as the first President of Therabis with the objective of significantly growing the brand's retail presence and sales.
"Therabis has tremendous potential as a product that can improve the quality of life for the pets which so many of us consider to be part of our families," said Chuck Smith, President and CEO, Dixie Brands. "We are very pleased to continue the national roll-out of the brand under Bob Rubin's leadership. Therabis is positioned for accelerated growth in 2019 as we broaden its distribution and continue to innovate with the introduction of feline and equine products, as well as ongoing additions to our existing canine line."
In his role at Therabis, Mr. Rubin will be responsible for executing on the compelling opportunities available to the brand as an early mover in the growing hemp-infused pet supplement category. Therabis plans to significantly expand its "bricks and mortar" presence in 2019 to complement its successful e-commerce platform, www.therabis.com. Therabis recently signed an agreement with Central Garden & Pet, a distributor with access to thousands of retail locations nationwide, and is targeting additional retail relationships.
3 Sixty Risk Solutions Ltd. today announced that 3 Sixty Secure Corp, a wholly-owned subsidiary of 3Sixty, has entered into a three-year master services agreement to provide security services to Canopy Growth Corporation across Canada. As part of the agreement, 3 Sixty Secure Corp. will provide 24/7 guarding services to protect Canopy Growth's Canadian facilities, as well as other security services as required. The agreement will include all existing and future Canopy Growth facilities across Canada. The agreement with Canopy Growth expands services to include all of its national facilities and extends the prior agreement from a one-year term to a three-year term.
"Reaching an agreement that extends and expands security services provided to Canopy Growth marks another important milestone for 3Sixty as we continue to assert ourselves as leaders in cannabis security," said Thomas Gerstenecker, CEO and Founder of 3Sixty. "I believe that our selection by Canopy Growth, a world-leading cannabis company, reaffirms the quality of our protective service offerings and supports our position as a leader in security services. Our sales pipeline is robust, and we are engaged with numerous companies seeking leading security solutions tailored to the cannabis industry and within non-core industries that require a full-spectrum of exceptional security services and solutions."
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment